[REVISION HISTORY]
Pancreatic cancer awareness and treatment developments
3 recorded revisions of this situation.
What changed
2026-11-20 00:01 UTC → 2026-11-20 00:31 UTC ·
added
removed
Medical awareness efforts have focused on pancreatic cancer through initiatives such as the “All Together We Can” campaign by PanCAN. This campaign seeks to raise 250 million US dollars over five years to support research, patient advocacy, and clinical trial access. In conjunction with World Pancreatic Cancer Day, new medical advancements have been reported. The European Commission has authorized the sale of Rasonque (daraxonrasib), developed by Revolution Medicines, for treating adults with metastatic pancreatic adenocarcinoma who have previously undergone systemic therapy. This authorization follows an accelerated assessment by the European Medicines Agency. In the phase III RASolute 302 clinical study, patients treated with the once-daily oral tablet showed a median overall survival of 12.4 to 13.2 months, compared to 6.7 months for those receiving standard chemotherapy. The drug also reportedly doubled the median time without disease progression from 3.6 to 7.2 months. The drug works by blocking RAS proteins to inhibit tumor growth and is indicated regardless of the presence of a Ras mutation. While the authorization applies across the EU, EEA, Iceland, Norway, and Liechtenstein, individual member states must determine pricing and reimbursement. In Italy, the Italian Medicines Agency is conducting a rolling review to expedite access, while patient associations in Spain are calling for expedited national funding processes. Technological progress is expanding in the diagnostic and surgical fields. In Spain, the ENDOGROUP at Centro Médico Teknon utilizes laser confocal endomicroscopy (EUS-nCLE) to differentiate between benign and malignant pancreatic cysts with high precision. Additionally, the Hospital Universitario Germans Trias i Pujol in Spain is employing Fujifilm Healthcare’s SYNAPSE 3D technology to create personalized anatomical models, which aids surgeons in planning complex procedures by visualizing tumor-vascular relationships. Regional efforts in Italy include the establishment of the SUD4PANCREAS network to improve prevention, diagnosis, and training in Southern Italy, specifically across Puglia, Basilicata, Campania, Calabria, Molise, and Sicily, alongside multidisciplinary care models and interactive sessions for patients and professionals.
Versions
- 2026-11-20 00:31 UTC Pancreatic cancer awareness and treatment developments
- 2026-11-20 00:01 UTC Pancreatic cancer awareness and treatment developments
- 2026-11-19 17:13 UTC Pancreatic cancer awareness and treatment developments
- 2026-11-19 10:06 UTC Pancreatic cancer awareness and treatment developments
Select a version to see what changed compared to the one before it.